Product Information
CHLORPROMAZINE 50 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.4145 per EA under NDC 62332073731. Its NADAC has been published 138 times since Feb 14, 2024.
FDA first approved this application on Jul 18, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332073731
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CHLORPROMAZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA217350FDA Approved
7/18/2023
TE Code
AB
On Market Since
7/20/2023
Pharmacological Classes
Price Statistics
The NADAC for CHLORPROMAZINE 50 MG TABLET has been published 138 times since Feb 14, 2024, and over the history we have for it it has declined 52.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4145 per EA |
|---|---|
| All-time high | $0.9267 (Sep 11, 2024) |
| All-time low | $0.3728 (May 20, 2026) |
| 52-week high | $0.6240 |
| 52-week low | $0.3728 |
| Median price | $0.4952 |
| Average price | $0.5347 |
| Largest weekly change | +58.0% (Aug 21, 2024) |
| Weeks tracked | 138 |
| Tracking since | Feb 14, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Chlorpromazine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Chlorpromazine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phenothiazine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHLORPROMAZINE 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CHLORPROMAZINE 50 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.4145 per EA (NDC 62332073731), effective Sep 30, 2026.
How has the price of CHLORPROMAZINE 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for CHLORPROMAZINE 50 MG TABLET has declined 52.5%. It has been tracked across 138 weekly CMS publications since Feb 14, 2024.
What are the highest and lowest recorded NADAC prices for CHLORPROMAZINE 50 MG TABLET?
Since Feb 14, 2024, the NADAC for CHLORPROMAZINE 50 MG TABLET has ranged from a low of $0.3728 (May 20, 2026) to a high of $0.9267 (Sep 11, 2024), with a median of $0.4952 per EA.
Are there cheaper alternatives to CHLORPROMAZINE 50 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of CHLORPROMAZINE 50 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CHLORPROMAZINE 50 MG TABLET?
CHLORPROMAZINE 50 MG TABLET (NDC 62332073731) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.